GSK3B and infection: Moreover, although it is well-known that during latency LANA-1 inhibits GSK-3β [112], we saw no effect of de novo infection on GSK-3β activity (Fig. S10), making this pathway unlikely to be involved in Nrf2 activation at the observed stage of infection.